Showing results (131-140 of 144) with videos related to
Sort By:
Pageof 15
Plos Pathogens|April 1, 2020
Combination immunotherapy with anti-PD-L1 antibody and depletion of regulatory T cells during acute viral infections results in improved virus control but lethal immunopathologyPaul David, Malgorzata Drabczyk-Pluta, Eva Pastille, et al.The Journal of Infectious Diseases|December 15, 2022
HIV-Associated Microbial Translocation May Affect Cytokine Production of CD56bright NK Cells via Stimulation of MonocytesMichael ToVinh, Gregor Hörr, Christoph Hoffmeister, et al.Science Translational Medicine|March 21, 2014
Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccinesAmy W Chung, Musie Ghebremichael, Hannah Robinson, et al.PLOS Global Public Health|April 8, 2025
In danger: HIV vaccine research and development in EuropeRoger Tatoud, Yves Lévy, Roger Le Grand, et al.Nature Communications|February 19, 2021
Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infectionsAlan Bénard, Anne Jacobsen, Maximilian Brunner, et al.Plos Pathogens|April 14, 2018
Limited immune surveillance in lymphoid tissue by cytolytic CD4+ T cells during health and HIV diseaseMarcus Buggert, Son Nguyen, Laura M McLane, et al.JACS Au|October 3, 2022
Advanced Molecular Tweezers with Lipid Anchors against SARS-CoV-2 and Other Respiratory VirusesTatjana Weil, Abbna Kirupakaran, My-Hue Le, et al.Mbio|January 25, 2022
Serological Markers of SARS-CoV-2 ReinfectionSameed M Siddiqui, Kathryn A Bowman, Alex L Zhu, et al.Nature Communications|May 19, 2023
Impaired humoral immunity to BQ.1.1 in convalescent and vaccinated patientsFelix Dewald, Martin Pirkl, Martha Paluschinski, et al.Infection|August 2, 2023
Estimates of protection levels against SARS-CoV-2 infection and severe COVID-19 in Germany before the 2022/2023 winter season: the IMMUNEBRIDGE projectBerit Lange, Veronika K Jaeger, Manuela Harries, et al.Pageof 15